Clinical study on cognitive impairment in Duchenne muscular dystrophy

被引:4
|
作者
Zhang, Xiao-Fang [1 ]
Luo, Yuan-Yuan [1 ]
Jiang, Li [1 ]
Hong, Si-Qi [1 ,2 ]
机构
[1] Chongqing Med Univ, Childrens Hosp, Natl Clin Res Ctr Child Hlth & Disorders,China Int, Dept Neurol,Minist Educ,Key Lab Child Dev & Disord, Chongqing, Peoples R China
[2] Chongqing Med Univ, Childrens Hosp, 2nd Zhongshan Rd, Chongqing, Peoples R China
关键词
Duchenne muscular dystrophy; Dystrophin; Cognitive impairment; Glucocorticoids; MEMORY; PERFORMANCE; TRANSCRIPT; CHILDREN; GENE; DP71;
D O I
10.1016/j.nmd.2023.06.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Our study aimed to explore the intellectual function of patients with Duchenne muscular dystrophy (DMD) in China and examine the correlation of full-scale intelligence quotient (FSIQ) with age, mutation locations, mutation class, and dystrophin isoforms. We assessed 64 boys with DMD using The Wechsler Intelligence Scales for Children-Fourth Edition and compared intellectual function at enrollment and follow-up in the 15 patients who completed the follow-up. Our findings confirm that boys with DMD may exhibit cognitive impairment, with the Working Memory Index being the most impaired. There was no significant correlation between FSIQ and age; however, a positive correlation was noted between age and the Verbal Comprehension Index. FSIQ was not associated with mutation class, the number of affected mutated exons, or mutation locations. However, there was a significant difference in FSIQ between the groups with intact and deficient Dp140. Fifteen participants adhered to glucocorticoid therapy throughout the two-year follow-up period, and eleven of them showed an improvement in FSIQ compared to their initial scores, with improvement ranging from 2 to 20. In conclusion, patients with the cumulative loss of isoforms in the brain are at a higher risk of cognitive deficits and may require early cognitive interventions.& COPY; 2023 Elsevier B.V. All rights reserved.
引用
收藏
页码:596 / 604
页数:9
相关论文
共 50 条
  • [31] Observational study of clinical outcomes for testosterone treatment of pubertal delay in Duchenne muscular dystrophy
    C. L. Wood
    T. D Cheetham
    K. G Hollingsworth
    M. Guglieri
    Y. Ailins-Sahun
    S. Punniyakodi
    A. Mayhew
    V. Straub
    BMC Pediatrics, 19
  • [32] Duchenne muscular dystrophy
    Yiu, Eppie M.
    Kornberg, Andrew J.
    NEUROLOGY INDIA, 2008, 56 (03) : 236 - 247
  • [33] Brain metabolite composition in relation to cognitive function and dystrophin mutations in boys with Duchenne muscular dystrophy
    Kreis, Roland
    Wingeier, Kevin
    Vermathen, Peter
    Giger, Elisabeth
    Joncourt, Franziska
    Zwygart, Karin
    Kaufmann, Franz
    Boesch, Chris
    Steinlin, Maja
    NMR IN BIOMEDICINE, 2011, 24 (03) : 253 - 262
  • [34] Duchenne muscular dystrophy
    Susan T. Iannaccone
    Zohair Nanjiani
    Current Treatment Options in Neurology, 2001, 3 (2) : 105 - 117
  • [35] Current and emerging therapies for Duchenne muscular dystrophy and spinal muscular atrophy
    Iftikhar, Mohsan
    Frey, Justin
    Shohan, Md Jasimuddin
    Malek, Sohail
    Mousa, Shaker A.
    PHARMACOLOGY & THERAPEUTICS, 2021, 220
  • [36] Duchenne muscular dystrophy
    von Moers, A.
    NERVENHEILKUNDE, 2011, 30 (10) : 805 - +
  • [37] Decreased cerebral perfusion in Duchenne muscular dystrophy patients
    Doorenweerd, Nathalie
    Dumas, Eve M.
    Ghariq, Eidrees
    Schmid, Sophie
    Straathof, Chiara S. M.
    Roest, Arno A. W.
    Wokke, Beatrijs H.
    van Zwet, Erik W.
    Webb, Andrew G.
    Hendriksen, Jos G. M.
    van Buchem, Mark A.
    Verschuuren, Jan J. G. M.
    Asllani, Iris
    Niks, Erik H.
    van Osch, Matthias J. P.
    Kan, Helinien E.
    NEUROMUSCULAR DISORDERS, 2017, 27 (01) : 29 - 37
  • [38] Duchenne Muscular Dystrophy Fatigue Trajectories
    Wei, Yi Sally
    Hnaini, Mona
    ElAloul, Basmah
    Zapata, Eugenio
    Campbell, Craig
    NEUROPEDIATRICS, 2024, 55 (01) : 42 - 48
  • [39] Gene therapy for Duchenne muscular dystrophy
    Suzuki, Naoki
    Miyagoe-Suzuki, Yuko
    Takeda, Shin'ichi
    FUTURE NEUROLOGY, 2007, 2 (01) : 87 - 96
  • [40] The Duchenne muscular dystrophy gene and cancer
    Jones, Leanne
    Naidoo, Michael
    Machado, Lee R.
    Anthony, Karen
    CELLULAR ONCOLOGY, 2021, 44 (01) : 19 - 32